Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

BHG Insider Trading

NeueHealth, Inc. | Hospital & Medical Service Plans

Comprehensive Trading Performance Summary

The investment history of corporate insiders at NeueHealth, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Hospital & Medical Service Plans sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2023-12-19 05:14 2023-12-15 Mikan George Lawrence III Director, Officer - CEO & President OPT+S $6.14 25,202 $154,740 29,927 0.0%
2023-10-07 01:50 2023-10-05 Matushak Jay Officer - Chief Financial Officer OPT+S $5.71 87 $497 2,861 0.0%
2023-08-18 02:48 2023-08-16 Cook Jeffrey S Officer - Chief Operating Officer OPT+S $10.84 1,232 $13,355 3,527 0.0%
2023-05-12 02:32 2023-05-10 Scherman Jeffrey J Officer - Chief Accounting Officer OPT+S $0.37 5,836 $2,159 79,420 0.0%
2023-03-16 03:32 2023-03-13 Craig Jeffery Michael Officer - GC & Corporate Secretary SELL $0.40 20,412 $8,165 33,643 -37.8%
2023-03-16 03:27 2023-03-13 Scherman Jeffrey J Officer - Chief Accounting Officer SELL $0.40 44,551 $17,820 57,870 -43.5%
2023-03-16 03:46 2023-03-13 Mikan George Lawrence III Director, Officer - CEO & President SELL $0.40 394,896 $157,958 210,318 -65.2%
2023-03-16 03:54 2023-03-13 Smith Cathy R Officer - CFO & CAO SELL $0.40 114,173 $45,669 289,157 -28.3%
2022-12-17 03:01 2022-12-14 Kadre Manuel Director BUY $0.65 185,000 $120,250 1,070,112 +20.9%
2022-12-17 03:30 2022-12-14 IMMELT JEFFREY R Director BUY $0.62 400,000 $248,000 598,012 +202.0%
2022-11-17 03:17 2022-11-14 Kadre Manuel Director BUY $0.96 303,307 $291,175 885,112 +52.1%
2022-11-15 03:45 2022-11-10 Kadre Manuel Director BUY $0.99 296,693 $293,518 294,888 +100.0%
2022-03-09 02:08 2022-03-04 Kadre Manuel Director BUY $2.10 200,000 $419,000 230,000 +666.7%
2021-12-15 03:33 2021-12-10 Kadre Manuel Director BUY $4.44 200,000 $887,600 130,000 +100.0%
2021-09-11 01:23 2021-09-08 Kadre Manuel Director BUY $9.59 100,000 $959,000 50,000 +100.0%
2021-08-26 03:34 2021-08-23 Newhall Adair Director BUY $10.34 48,694 $503,326 48,694 +100.0%
2021-08-18 00:03 2021-08-13 Kadre Manuel Director BUY $8.71 23,339 $203,371 80,000 +41.2%
2021-08-14 00:20 2021-08-11 Kadre Manuel Director BUY $8.43 6,661 $56,152 56,661 +13.3%
2021-07-01 04:29 2021-06-28 Chang Carmen 10% owner BUY $18.00 1,944,444 $34,999,992 23,983,073 +8.8%
2021-07-01 04:31 2021-06-28 Makhzoumi Mohamad Director, 10% owner BUY $18.00 1,944,444 $34,999,992 23,983,073 +8.8%
2021-07-01 04:28 2021-06-28 Behbahani Ali 10% owner BUY $18.00 1,944,444 $34,999,992 23,983,073 +8.8%
2021-07-01 04:30 2021-06-28 Florence Anthony A. Jr. 10% owner BUY $18.00 1,944,444 $34,999,992 23,983,073 +8.8%
2021-07-01 04:33 2021-06-28 Sonsini Peter W. 10% owner BUY $18.00 1,944,444 $34,999,992 23,983,073 +8.8%
2021-07-01 04:33 2021-06-28 Walker Paul Edward 10% owner BUY $18.00 1,944,444 $34,999,992 23,983,073 +8.8%
2021-07-01 04:28 2021-06-28 BASKETT FOREST 10% owner BUY $18.00 1,944,444 $34,999,992 23,983,073 +8.8%
2021-07-01 04:32 2021-06-28 SANDELL SCOTT D 10% owner BUY $18.00 1,944,444 $34,999,992 23,983,073 +8.8%
2021-07-01 04:31 2021-06-28 MAKOWER JOSHUA 10% owner BUY $18.00 1,944,444 $34,999,992 23,983,073 +8.8%
SHOW ENTRIES

How to Interpret $BHG Trades

Not every insider transaction in NeueHealth, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $BHG shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for BHG

Insider activity data for NeueHealth, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $BHG, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.